Meet Our Team

Aaron Tsai is a Partner at Vesselbridge Capital, where he leads advisory activities across public markets and structured capital transactions, including private placements, pre-IPO financings, and cross-border public market strategies. He is also the Founder and Managing Partner of MAS Capital Inc., an international capital markets advisory platform advising on public and private market transactions across Asia, the United States, and Europe.

Aaron began his career as an investment banker on Wall Street and is widely recognised for his early leadership in public market structuring, having been instrumental in the execution of over 100 public shell companies prior to the emergence of SPACs. His transaction experience spans private placements, PIPEs, IPOs, secondary offerings, reverse mergers, and cross-border M&A. In total Aaron has led and advised on public market and structured capital transactions with aggregate value in excess of over $30bn.

Pierre Mechen is Managing Partner of Vesselbridge Capital, where he leads the firm’s corporate finance advisory activities across capital raising, cross-border M&A, and strategic transactions in private and public markets. He advises founders, shareholders, and management teams on capital strategy, transaction positioning, and execution across complex and cross-border situations. He also serves as a Partner and European Director at MAS Capital Inc., where he advises on European-facing mandates across private placements, pre-IPO structuring, public market transactions, and post-listing capital strategy.

At Vesselbridge, Pierre leads transaction structuring and strategic positioning, working directly with senior banking, legal, and exchange counterparts on institutional-grade mandates. His work is centred on disciplined preparation, institutional investor engagement, and outcome-oriented advisory across the full corporate lifecycle through to liquidity events and exit.

Responsible for investor relations and due diligence support across active mandates, including data room management and transaction execution. Antonis has extensive experience in sell-side and buy-side M&A, IPOs, and private placements. He has deep expertise in financial modelling, valuation, and market analysis. He is also a senior Advisor at a family office looking at equity investments and alternative asset managers with a particular focus on Technology.

León leads investor coverage and qualification across mandates, overseeing opportunity screening, investor targeting, and process management throughout live transactions. He ensures alignment between issuer objectives and investor appetite, supporting execution through structured investor engagement, feedback integration, and disciplined process coordination across active capital raises and M&A mandates.

Leads the preparation of all investor-facing materials across capital raises and M&A mandates, including Information Memoranda, pitch decks, and supporting transaction documentation. Jovan partners with execution and investor teams to deliver clear, institutional-grade narratives, ensuring materials support informed investor decision-making and efficient transaction execution.

Mary serves as Investor Relations Coordinator for the Asia-Pacific region, supporting investor coverage, qualification, and outreach across active mandates, including investor mapping and pipeline management. She supports execution through structured investor communication, cross-border coordination, and the development of internal systems, including CRM infrastructure and reporting processes that enhance efficiency across APAC transactions.

Grant Fagan is a Senior Advisor to Vesselbridge Capital, supporting capital markets, M&A, and complex strategic finance transactions globally. Over a 35+ year career, he has advised boards, financial sponsors, and executive teams on large-scale debt and equity financings, restructurings, and corporate transactions, contributing to $50+ billion in capital raised.

He previously held senior roles across Deloitte and leading international investment banks including Barclays, ABN Amro, Rand Merchant Bank, and Nedcor Capital, and has founded and scaled multiple advisory and investment platforms. Grant brings board-level judgment and hands-on execution experience across growth, turnaround, and capital formation mandates.

Yasir Hassan is a seasoned entrepreneur and investor with over 20 years' experience at the intersection of data, technology, and life sciences. As Founder of Health iQ, he built and scaled a leading UK-based real-world evidence research and technology business, taking it from inception to exit. Following its acquisition by CorEvitas, he joined as Chief Product Officer, serving on the Board and M&A committee as the company grew into a global RWE platform before its $1 billion sale to Thermo Fisher Scientific in 2023.

This blend of scientific rigour and commercial acumen is central to what Yasir brings as an advisor. He has led commercial strategy across the full spectrum, from enterprise sales and business development through to M&A and has supported market access programmes for some of the most significant therapeutic launches of the past two decades, spanning PCSK9 inhibitors, CAR-T therapies, checkpoint inhibitors, and oral GLP-1s, among others.

Yasir now serves as Venture Partner at Y-Innovations, a leading US-based life sciences investor, and is Founder of Beaufort Advisory, supporting biotech and med-tech companies with investment strategy and fundraising across the UK, US, and Saudi Arabia.

As Board Advisor for Life Sciences at Vesselbridge Capital, Yasir offers a rare combination of deep scientific familiarity, hands-on founder experience, and sophisticated buy- and sell-side investment expertise, making him a distinctive asset to Vesselbridge's life sciences clients navigating capital formation, M&A, and strategic transactions.